Results 81 to 90 of about 150 (93)

Comunicaciones LX Reunión Anual SENFC Barcelona, 2 a 4 de octubre de 2024. [PDF]

Rev Neurol
europepmc   +1 more source

[Optical coherence tomography as a predictor of visual recovery in patients with pituitary macroadenomas].

Surg Neurol Int, 2018
Beltrame S, Rasmussen J, Plou P, Altszul M, Yampolsky C, Ajler P.   +5 more
europepmc   +1 more source

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. [PDF]

Br J Ophthalmol, 2015
Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R, Hoyng CB, Hykin P, Staurenghi G, Heldner S, Bogumil T, Heah T, Sivaprasad S.   +12 more
europepmc   +1 more source

Informed consent in patients undergoing eye surgery: A qualitative study assessing their attitude, knowledge and anxiety level in a community based hospital of Nepal Consentimiento informado en pacientes sometidos a cirugía ocular: estudio cualitativo de evaluación de su nivel de actitud, conocimiento y ansiedad en un hospital comunitario de Nepal [PDF]

Journal of optometry, 2013
Marasini S, Kaiti R, Mahato R, Gyawali R, Nepal B.   +4 more
europepmc   +1 more source

Proliferative vitreoretinopathy: current and emerging treatments. [PDF]

Clin Ophthalmol, 2012
Sadaka A, Giuliari GP.
europepmc   +1 more source

Vitreoretinal surgery for macular hole after laser assisted in situ keratomileusis for the correction of myopia. [PDF]

Br J Ophthalmol, 2005
Arevalo JF, Rodriguez FJ, Rosales-Meneses JL, Dessouki A, Chan CK, Mittra RA, Ruiz-Moreno JM.   +6 more
europepmc   +1 more source

[Marfan's syndrome]. [PDF]

Aten Primaria, 2009
Valderrama Zurián FJ, Martín Gutiérrez V, Sorlí JV, Mingarro Castillo M, Ejarque Doménech I, Ortiz Uriarte R, García Ribes M.   +6 more
europepmc   +1 more source

Prediabetes in Colombia: Expert Consensus. [PDF]

Colomb Med (Cali), 2017
López-Jaramillo P, Calderón C, Castillo J, Escobar ID, Melgarejo E, Parra GA.   +5 more
europepmc   +1 more source

The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy. [PDF]

PLoS One, 2013
Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutiérrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, MacLaren RE, Charteris D, VanMeurs JC, González-Sarmiento R, Pastor JC, Genetics on PVR Study Group.   +14 more
europepmc   +1 more source